Business · 12/11/2020Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Collection of Information for In Vivo Radiopharmaceuticals
Summary
The Food and Drug Administration is seeking public input on its proposed collection of information related to in vivo radiopharmaceuticals used for diagnosis and monitoring, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →